Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OncoSec Medical Inc ONCSQ

Healthcare Biotechnology
OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec... see more

Recent & Breaking News (GREY:ONCSQ)

Exclusive Video Interviews With CEOs Now on Equities.com: AHRO, AMBS, MTST, ONCS, TRGM

Globe Newswire October 9, 2013

OncoSec Medical Announces Positive Preliminary Safety Data in Combination Study

Business Wire October 8, 2013

OncoSec Medical to Present at the 12th Annual BIO Investor Forum

Business Wire October 3, 2013

OncoSec Medical to Present at the Cancer Vaccines and Gene Therapy Meeting

Business Wire October 1, 2013

OncoSec Announces Melanoma Development Strategy

Business Wire September 24, 2013

Shutterstock Zooms to a new 52-week High after Pricing Secondary Offering

Accesswire September 23, 2013

OncoSec Medical to Present at the 2013 Aegis Capital Healthcare Conference

Business Wire September 20, 2013

OncoSec Medical Closes $12 Million Public Offering

Business Wire September 19, 2013

OncoSec Medical Announces $12 Million Public Offering

Business Wire September 16, 2013

OncoSec Medical to Present at the 15th Annual Rodman & Renshaw Global Investment Conference

Business Wire September 4, 2013

OncoSec Medical Presents Positive Immune Response Data from Phase II Study at the 8th World Congress of Melanoma

Business Wire July 22, 2013

OncoSec Medical Featured on San Francisco's KGO-TV Channel 7

Business Wire July 19, 2013

OncoSec Medical to Host Satellite Symposium at the 8th World Congress of Melanoma in Hamburg, Germany on July 17

Business Wire July 15, 2013

OncoSec Medical Announces Completion of Enrollment of Phase II Metastatic Melanoma Trial

Business Wire June 18, 2013

OncoSec Medical Enters Sponsored Research Agreement with Old Dominion University for Combination Study in Melanoma

Business Wire June 11, 2013

OncoSec Medical to Present at the Second Annual Marcum LLP MicroCap Conference

Business Wire May 21, 2013

PennyStocks.com Announces Trade Alerts on: XUII, MULI, ONCS, and APDN

Marketwired May 16, 2013

OncoSec Medical Incorporated President and CEO Publishes New Blog Entitled ''Why Electroporation?''

Accesswire May 10, 2013

PennyStocks.com Announces Trade Alerts on: WSGP, ONCS, TTNP, and NDEV

Marketwired May 8, 2013

OncoSec Medical to Present at the Sachs Cancer Bio Partnering Forum and Participate in a Panel Discussion on Immunotherapies and Cancer Vaccines

Business Wire May 7, 2013